Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 216

1.

3,4-diaminopyridine safety in clinical practice: an observational, retrospective cohort study.

Flet L, Polard E, Guillard O, Leray E, Allain H, Javaudin L, Edan G.

J Neurol. 2010 Jun;257(6):937-46. doi: 10.1007/s00415-009-5442-6. Epub 2010 Jan 8.

PMID:
20058019
2.

Evaluating patient satisfaction with specific migraine therapy based on initial treatment expectations: the PAX study.

Lantéri-Minet M, Allain H, Druais PL, Meric G, Troy S.

Curr Med Res Opin. 2010 Feb;26(2):465-72. doi: 10.1185/03007990903507693.

PMID:
20001575
3.

[Prescription of aspirin in recent acute painful disorders: results of a survey among French general practitioners].

Bannwarth B, Allaert FA, Dubreuil C, Allain H, Azerad J, Becq JP, Trèves R, Valade D.

Therapie. 2007 Nov-Dec;62(6):477-81. doi: 10.2515/therapie:2007075. Epub 2008 Mar 4. French.

PMID:
18316013
4.

Disease-modifying drugs and Parkinson's disease.

Allain H, Bentué-Ferrer D, Akwa Y.

Prog Neurobiol. 2008 Jan;84(1):25-39. Epub 2007 Oct 16. Review.

PMID:
18037225
5.

A prospective, multicentre, open-label study of aripiprazole in the management of patients with schizophrenia in psychiatric practice in Europe: Broad Effectiveness Trial with Aripiprazole in Europe (EU-BETA).

Wolf J, Janssen F, Lublin H, Salokangas RK, Allain H, Smeraldi E, Bernardo M, Millar H, Pans M, Adelbrecht C, Laughton J, Werner C, Maier W.

Curr Med Res Opin. 2007 Oct;23(10):2313-23.

PMID:
17706003
6.

Treatment of the mild cognitive impairment (MCI).

Allain H, Bentué-Ferrer D, Akwa Y.

Hum Psychopharmacol. 2007 Jun;22(4):189-97. Review.

PMID:
17415706
7.

On the interest of computer modelling in the validation of ambulatory measurement of movement disorders in man.

Le Cavorzin P, Carrault G, Chagneau F, Rochcongar P, Allain H.

Conf Proc IEEE Eng Med Biol Soc. 2005;5:5443-4.

PMID:
17281484
8.

Impaired cognition and attention in adults: pharmacological management strategies.

Allain H, Akwa Y, Lacomblez L, Lieury A, Bentué-Ferrer D.

Neuropsychiatr Dis Treat. 2007 Feb;3(1):103-16.

9.

Improvement in quality of life after initiation of lamotrigine therapy in patients with epilepsy in a naturalistic treatment setting.

Allain H, Schück S, Nachit-Ouinekh F, Plouin P, Brunon AM, Boulliat J, Mercier F, Slama A, Baulac M, El Hasnaoui A.

Seizure. 2007 Mar;16(2):173-84. Epub 2007 Jan 8.

10.

Effects of acute fluoxetine, paroxetine and desipramine on rats tested on the elevated plus-maze.

Drapier D, Bentué-Ferrer D, Laviolle B, Millet B, Allain H, Bourin M, Reymann JM.

Behav Brain Res. 2007 Jan 25;176(2):202-9. Epub 2006 Nov 13.

PMID:
17095104
11.

Pathological gambling secondary to dopaminergic therapy in Parkinson's disease.

Drapier D, Drapier S, Sauleau P, Derkinderen P, Damier P, Allain H, Vérin M, Millet B.

Psychiatry Res. 2006 Nov 15;144(2-3):241-4. Epub 2006 Oct 2.

PMID:
17011634
12.

The anti-dementia drugs: myth, hype or reality?

Allain H, Bentué-Ferrer D.

Clin Neuropharmacol. 2006 Jan-Feb;29(1):10-4. Erratum in: Clin Neuropharmacol. 2006 May-Jun;29(3):185. Hervé, Allain [corrected to Allain, Hervé].

PMID:
16518127
13.

Neuroprotection and neurodegenerative diseases: from biology to clinical practice.

Akwa Y, Allain H, Bentue-Ferrer D, Berr C, Bordet R, Geerts H, Nieoullon A, Onteniente B, Vercelletto M.

Alzheimer Dis Assoc Disord. 2005 Oct-Dec;19(4):226-39. Review.

PMID:
16327350
14.

[Consensus statement on severe dementia].

Vellas B, Gauthier S, Allain H, Andrieu S, Aquino JP, Berrut G, Berthel M, Blanchard F, Camus V, Dartigues JF, Dubois B, Forette F, Franco A, Gonthier R, Grand A, Hervy MP, Jeandel C, Joel ME, Jouanny P, Lebert F, Michot P, Montastruc JL, Nourhashemi F, Ousset PJ, Pariente J, Rigaud AS, Robert P, Ruault G, Strubel D, Touchon J, Verny M, Vetel JM; French Society of Gerontology and Geriatrics.

Presse Med. 2005 Nov 19;34(20 Pt 1):1545-55. French.

PMID:
16301969
15.

Retransplantation for acute liver failure due to combined antiviral agents in an HIV-HCV coinfected liver transplant recipient.

Polard E, Camus C, Abault AY, Turlin B, Arvieux C, Messner M, Allain H, Boudjema K.

Transplantation. 2005 Oct 27;80(8):1136-8. No abstract available.

PMID:
16278602
16.

[Consensus statement on severe dementia].

Vellas B, Gauthier S, Allain H, Andrieu S, Aquino JP, Berrut G, Berthel M, Blanchard F, Camus V, Dartigues JF, Dubois B, Forette F, Franco A, Gonthier R, Grand A, Hervy MP, Jeandel C, Joel ME, Jouanny P, Lebert F, Michot P, Montastruc JL, Nourhashemi F, Ousset PJ, Pariente J, Rigaud AS, Robert P, Ruault G, Strubel D, Touchon J, Verny M, Vetel JM; French Society of Gerontology and Geriatrics.

Rev Neurol (Paris). 2005 Sep;161(8-9):868-77. French.

PMID:
16244574
17.

Consensus statement on dementia of Alzheimer type in the severe stage.

Vellas B, Gauthier S, Allain H, Andrieu S, Aquino JP, Berrut G, Berthel M, Blanchard F, Camus V, Dartigues JF, Dubois B, Forette F, Franco A, Gonthier R, Grand A, Hervy MP, Jeandel C, Joel ME, Jouanny P, Lebert F, Michot P, Montastruc JL, Nourhashemi F, Ousset PJ, Pariente J, Rigaud AS, Robert P, Ruault G, Strubel D, Touchon J, Verny M, Vetel JM.

J Nutr Health Aging. 2005 Sep-Oct;9(5):330-8. Review. No abstract available.

PMID:
16222399
18.

Postural instability and consequent falls and hip fractures associated with use of hypnotics in the elderly: a comparative review.

Allain H, Bentué-Ferrer D, Polard E, Akwa Y, Patat A.

Drugs Aging. 2005;22(9):749-65. Review.

PMID:
16156679
19.

Double-blind study of cyamemazine and diazepam in the alcohol withdrawal syndrome.

Favre JD, Allain H, Aubin HJ, Frija-Orvoen E, Gillet C, Lejoyeux M, Payen A, Weber M, Garcia-Acosta S, Kermadi I, Dib M.

Hum Psychopharmacol. 2005 Oct;20(7):511-9.

PMID:
16118830
20.

[Pharmacology of Alzheimer's disease: where do we go from here?].

Sellal F, Nieoullon A, Michel G, Michel BF, Lacomblez L, Geerts H, Delini-Stula A, Bentué-Ferrer D, Bordet R, Allain H.

Therapie. 2005 Mar-Apr;60(2):89-107. Review. French.

PMID:
15969312
21.

Simultaneous quantitative assay of atazanavir and 6 other HIV protease inhibitors by isocratic reversed-phase liquid chromatography in human plasma.

Tribut O, Verdier MC, Arvieux C, Allain H, Michelet C, Bentué-Ferrer D.

Ther Drug Monit. 2005 Jun;27(3):265-9.

PMID:
15905793
22.

[Pharmacological treatment in severe dementia].

Jouanny P, Belliard S, Bentué-Ferrer D, Michel O, Allain H.

Psychol Neuropsychiatr Vieil. 2005 Mar;3 Suppl 1:S51-5. French.

PMID:
15899605
23.

Pharmacology of Alzheimer's disease: appraisal and prospects.

Sellal F, Nieoullon A, Michel G, Michel BF, Lacomblez L, Geerts H, Delini Stula A, Bordet R, Bentué-Ferrer D, Allain H.

Dement Geriatr Cogn Disord. 2005;19(5-6):229-45. Epub 2005 Mar 11. Review.

24.

Major discrepancy between digoxin immunoassay results in a context of acute overdose: a case report.

Tribut O, Gaulier JM, Allain H, Bentué-Ferrer D.

Clin Chim Acta. 2005 Apr;354(1-2):201-3. Epub 2004 Nov 24. No abstract available.

PMID:
15748618
25.

[Biology of motivation].

Allain H, Bentué-Ferrer D, Lacomblez L.

Psychol Neuropsychiatr Vieil. 2004 Sep;2(3):167-72. Review. French.

26.

[What is dementia? 5. "Anti-dementia" drug: myth or reality?].

Allain H, Bentue-Ferrer D.

Psychol Neuropsychiatr Vieil. 2003 Sep;1(3):151-6. Review. French.

27.

Gentamicin-loaded calcium carbonate materials: comparison of two drug-loading modes.

Lucas-Girot A, Verdier MC, Tribut O, Sangleboeuf JC, Allain H, Oudadesse H.

J Biomed Mater Res B Appl Biomater. 2005 Apr;73(1):164-70.

PMID:
15678498
28.

The PROMISE study: PROphylaxis of MIgraine with SEglor (dihydroergotamine mesilate) in French primary care.

Pradalier A, Lantéri-Minet M, Géraud G, Allain H, Lucas C, Delgado A.

CNS Drugs. 2004;18(15):1149-63.

PMID:
15581385
29.

Does rat global transient cerebral ischemia serve as an appropriate model to study emotional disturbances?

Bantsiele GB, Bentué-Ferrer D, Amiot N, Allain H, Bourin M, Reymann JM.

Fundam Clin Pharmacol. 2004 Dec;18(6):685-92.

PMID:
15548240
30.

[Mechanisms of chronic cough pathophysiology].

Allain H, Bentue-Ferrer D, Daval G, Polard E, Delaval P, Lagente V.

Rev Mal Respir. 2004 Sep;21(4 Pt 1):763-8. Review. French.

PMID:
15536377
31.

[NOEMIE: an epidemiological study of migraine at work: results from 17 occupational health centres].

Lantéri-Minet M, Allain H, Nachit-Ouinekh F, Bentué-Ferrer D, Gilbert P, Schück S, El Hasnaoui A; Comité d'Orientation National.

Rev Neurol (Paris). 2004 Oct;160(10):928-34. French.

PMID:
15492719
32.

Mild cognitive impairment: a treatment at last?

Allain H, Bentué-Ferrer D, Akwa Y.

Lancet Neurol. 2004 Nov;3(11):643. Review. No abstract available.

PMID:
15488455
33.

Safety of calcium dobesilate in chronic venous disease, diabetic retinopathy and haemorrhoids.

Allain H, Ramelet AA, Polard E, Bentué-Ferrer D.

Drug Saf. 2004;27(9):649-60. Review.

PMID:
15230646
34.

The anti-dementia drugs: myth, hype or reality?

Allain H, Bentué-Ferrer D.

Curr Opin Neurol. 2003 Dec;16 Suppl 2:S23-7. Review.

PMID:
15129847
35.

Drug induced encephalopathy in six epileptic patients: topiramate? valproate? or both?

Latour P, Biraben A, Polard E, Bentué-Ferrer D, Beauplet A, Tribut O, Allain H.

Hum Psychopharmacol. 2004 Apr;19(3):193-203.

PMID:
15079854
36.

[Myoclonic encephalopathy associated with proton pump inhibitors].

Boulliat J, Polard E, Colin F, Bentué-Ferrer D, Allain H.

Rev Neurol (Paris). 2004 Mar;160(3):350-1. French.

PMID:
15037850
37.

A computer model of rigidity and related motor dysfunction in Parkinson's disease.

Le Cavorzin P, Carrault G, Chagneau F, Rochcongar P, Allain H.

Mov Disord. 2003 Nov;18(11):1257-65.

PMID:
14639665
38.

Clinically significant drug interactions with cholinesterase inhibitors: a guide for neurologists.

Bentué-Ferrer D, Tribut O, Polard E, Allain H.

CNS Drugs. 2003;17(13):947-63. Review.

PMID:
14533945
39.

[Ludopathy induced by levodopa associated with bromocriptin].

Polard E, Trioux E, Flet L, Colin F, Allain H.

Presse Med. 2003 Aug 9;32(26):1223. French. No abstract available.

PMID:
14506463
40.

The challenge of chronic insomnia: is non-nightly hypnotic treatment a feasible alternative?

Hajak G, Cluydts R, Allain H, Estivill E, Parrino L, Terzano MG, Walsh JK.

Eur Psychiatry. 2003 Aug;18(5):201-8. Review.

PMID:
12927320
41.

Alzheimer's disease: the pharmacological pathway.

Allain H, Bentué-Ferrer D, Tribut O, Gauthier S, Michel BF, Drieu-La Rochelle C.

Fundam Clin Pharmacol. 2003 Aug;17(4):419-28. Review.

PMID:
12914543
42.

Preference of insomniac patients between a single dose of zolpidem 10 mg versus zaleplon 10 mg.

Allain H, Bentué-Ferrer D, Breton SL, Polard E, Gandon JM.

Hum Psychopharmacol. 2003 Jul;18(5):369-74.

PMID:
12858323
44.

Drugs and vascular dementia.

Allain H, Bentue-Ferrer D, Tribut O, Pinel JF.

Dement Geriatr Cogn Disord. 2003;16(1):1-6. Review.

PMID:
12714793
45.

Effects of nicardipine and clonidine on cognitive functions and electroencephalography in hypertensive patients.

Denolle T, Sassano P, Allain H, Bentué-Ferrer D, Breton S, Cimarosti I, Ouatara B, Merienne M, Gandon JM.

Fundam Clin Pharmacol. 2002 Dec;16(6):527-35.

PMID:
12685512
46.

Drug therapy of frontotemporal dementia.

Allain H, Bentué-Ferrer D, Tribut O, Mérienne M, Belliard S.

Hum Psychopharmacol. 2003 Apr;18(3):221-5. Review.

PMID:
12672175
47.

[Mild Cognitive Impairment: potential therapeutics].

Allain H, Bentue-Ferrer D, Belliard S, Reymann JM, Djemaï M, Merienne M.

Rev Neurol (Paris). 2002;158(10 Suppl):S35-40. Review. French.

PMID:
12529584
48.

[Evaluation of pendulum testing of spasticity].

Le Cavorzin P, Hernot X, Bartier O, Carrault G, Chagneau F, Gallien P, Allain H, Rochcongar P.

Ann Readapt Med Phys. 2002 Nov;45(9):510-6. French.

PMID:
12495824
49.

Effects of risperidone on psychometric and cognitive functions in healthy elderly volunteers.

Allain H, Tessier C, Bentué-Ferrer D, Tarral A, Le Breton S, Gandon M, Bouhours P.

Psychopharmacology (Berl). 2003 Feb;165(4):419-29. Epub 2002 Nov 30.

PMID:
12459926
50.

[Study of the real situation of improvement by Zopiclone in treatment of insomnia among persons working during night shifts].

Quera-Salva MA, Philip P, Taillard J, Letrequeser R, Allain H, Garcia-Acosta S, Kermad I, Krieger J, Dib M.

Rev Neurol (Paris). 2002 Nov;158(11):1102-6. French.

PMID:
12451343

Supplemental Content

Loading ...
Support Center